Pathway Healths Lisa Thomson Receives 2026 McKnights Pinnacle Award
LAKE ELMO, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Pathway Health, a…
Bring the Cheer, Pack the Gear: Game On This Holiday Season
LAUSANNE, Switzerland, Dec. 16, 2025 (GLOBE NEWSWIRE) -- As the year winds…
Cholame Finance Academy Finalizes Comprehensive Data Protection Upgrade with Rupert Ellingtons Oversight
Cholame Finance Academy, guided by Rupert Ellington, has completed a comprehensive data…
VivoPower Announces Update to Annual General Meeting
LONDON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR),…
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
– Company to host live webcast and conference call Monday, December 15,…
Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian…
Mutuum Finance (MUTM) Completes Smart Contracts in Preparation for Q4 2025 Testing
Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a…
Free Spins No Deposit Casino | Real Money Online Casino No Deposit Bonus By Cafe Casino
New York City, NY, Dec. 13, 2025 (GLOBE NEWSWIRE) -- . Free…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…